| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.878 | 0.007 | 0.91 | Antiinflammatory | 0.91 0.005 DBMET00161 | DBMET00161 | |
| 0.845 | 0.003 | 0.845 | Cyclooxygenase 1 inhibitor | 0.844 0.003 DBMET00161 | ||
| 0.83 | 0.005 | 0.924 | Analgesic | 0.924 0.004 DBMET00161 | DBMET00161 | |
| 0.705 | 0.003 | 0.705 | Cyclooxygenase inhibitor | 0.665 0.004 DBMET00161 | ||
| 0.671 | 0.011 | 0.811 | Toll-Like receptor 7 agonist | 0.811 0.005 DBMET00161 | DBMET00161 | |
| 0.664 | 0.011 | 0.805 | Toll-Like receptor agonist | 0.805 0.005 DBMET00161 | DBMET00161 | |
| 0.546 | 0.005 | 0.546 | Non-steroidal antiinflammatory agent | 0.319 0.024 DBMET00161 | ||
| 0.492 | 0.02 | 0.492 | Lipoxygenase inhibitor | 0.261 0.093 DBMET00161 | ||
| 0.388 | 0.006 | 0.393 | Cyclooxygenase 2 inhibitor | 0.393 0.005 DBMET00161 | DBMET00161 | |
| 0.228 | 0.044 | 0.228 | Anticoagulant | 0.188 0.058 DBMET00161 | ||
| 0.142 | 0.007 | 0.142 | Factor X inhibitor | 0.097 0.011 DBMET00161 | ||
| 0.116 | 0.018 | 0.116 | Potassium channel large-conductance Ca-activated activator | 0.092 0.028 DBMET00161 | ||
| 0.269 | 0.192 | 0.269 | Cyclophilin D inhibitor | 0.25 0.213 DBMET00161 | ||
| 0.109 | 0.04 | 0.109 | Potassium channel activator | |||
| 0.248 | 0.189 | 0.248 | Alpha-glucosidase inhibitor | |||
| 0.058 | 0.005 | 0.058 | Protocollagen prolyl hydroxylase inhibitor | |||
| 0.067 | 0.017 | 0.067 | Glucose-6-phosphate translocase inhibitor | 0.064 0.02 DBMET00161 | ||
| 0.126 | 0.087 | 0.126 | CC chemokine 6 receptor antagonist | 0.122 0.109 DBMET00161 | ||
| 0.018 | 0.014 | 0.018 | Potassium channel (Inward rectifier) 11 blocker | |||
| 0.02 | 0.056 | 0.047 | Nicotinic acid receptor agonist | 0.047 0.016 DBMET00161 | DBMET00161 | |
| 0.02 | 0.065 | 0.091 | Nicotinic acid receptor 2 agonist | 0.091 0.006 DBMET00161 | DBMET00161 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |